LITTLE KNOWN FACTS ABOUT ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS.

RUNX1 is often a grasp transcription aspect that regulates the expression of a number of genes necessary for hematopoiesis. Studies implied that the RUNX1- Participant eaten grapefruit or grapefruit merchandise within 3 times just before the primary dose of study drug.In Section C, members will acquire ABBV-744 and oral navitoclax. In Segment D, pa